From January 1, 2022 to March 31, 2022, the company has repurchased 4,478,900 shares, representing 0.82% for CNY 69.74 million. With this, the company has completed the repurchase of 11,355,900 shares, representing 2.09% for CNY 174.83 million under the buyback announced on August 4, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.45 CNY | -3.87% | -8.25% | +0.96% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.96% | 73Cr | |
+43.16% | 75TCr | |
+34.11% | 61TCr | |
-6.54% | 36TCr | |
+19.03% | 33TCr | |
+6.99% | 29TCr | |
+18.08% | 25TCr | |
-3.44% | 21TCr | |
+11.35% | 21TCr | |
+2.00% | 17TCr |
- Stock Market
- Equities
- 300497 Stock
- News Jiangxi Fushine Pharmaceutical Co., Ltd.
- Tranche Update on Jiangxi Fushine Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 4, 2021.